[Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].
Yoshioka
A
A
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control* / Q000635:transmission; D004340:Drug Contamination / Q000517:prevention & control*; D005169:Factor VIII / Q000032:analysis / Q000302:isolation & purification*; D005337:Fibrin / Q000032:analysis; D006467:Hemophilia A / Q000628:therapy*; D006358:Hot Temperature; D006801:Humans; D014841:von Willebrand Factor / Q000032:analysis
D014841:von Willebrand Factor; D005169:Factor VIII; D005337:Fibrin